Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mixed dementia: A review of the evidence
Nilton Custodio, Rosa Montesinos, David Lira, et al.
Dementia & Neuropsychologia (2017) Vol. 11, Iss. 4, pp. 364-370
Open Access | Times Cited: 112

Showing 1-25 of 112 citing articles:

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders
Anuradha Tarafdar, Giordano Pula
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 12, pp. 3824-3824
Open Access | Times Cited: 317
Vascular Dysfunction in Alzheimer’s Disease: A Prelude to the Pathological Process or a Consequence of It?
Karan Govindpani, Laura G McNamara, Nicholas R Smith, et al.
Journal of Clinical Medicine (2019) Vol. 8, Iss. 5, pp. 651-651
Open Access | Times Cited: 217
Diagnostic biomarkers of Alzheimer’s disease: A state-of-the-art review
Rita Khoury, Elias Ghossoub
Biomarkers in Neuropsychiatry (2019) Vol. 1, pp. 100005-100005
Open Access | Times Cited: 157
Machine Learning for Dementia Prediction: A Systematic Review and Future Research Directions
Ashir Javeed, Ana Luiza Dallora, Johan Berglund, et al.
Journal of Medical Systems (2023) Vol. 47, Iss. 1
Open Access | Times Cited: 86
Alzheimer's disease and alpha-synuclein pathology in the olfactory bulbs of infants, children, teens and adults ≤ 40 years in Metropolitan Mexico City. APOE4 carriers at higher risk of suicide accelerate their olfactory bulb pathology
Lilian Calderón‐Garcidueñas, Angélica González-Maciel, Rafael Reynoso-Robles, et al.
Environmental Research (2018) Vol. 166, pp. 348-362
Closed Access | Times Cited: 96
Hypertension and hyperhomocysteinemia as modifiable risk factors for Alzheimer's disease and dementia: New evidence, potential therapeutic strategies, and biomarkers
Ashley M Carey, Silvia Fossati
Alzheimer s & Dementia (2022) Vol. 19, Iss. 2, pp. 671-695
Open Access | Times Cited: 43
Sex differences in dementia risk and risk factors: Individual‐participant data analysis using 21 cohorts across six continents from the COSMIC consortium
Jessica Gong, Katie Harris, Darren M. Lipnicki, et al.
Alzheimer s & Dementia (2023) Vol. 19, Iss. 8, pp. 3365-3378
Open Access | Times Cited: 37
Viruses and the Brain—A Relationship Prone to Trouble
Matylda Barbara Mielcarska, Barry T. Rouse
Viruses (2025) Vol. 17, Iss. 2, pp. 203-203
Open Access | Times Cited: 1
Biomarkers of dementia in obstructive sleep apnea
Andrée‐Ann Baril, Julie Carrier, Alexandre Lafrenière, et al.
Sleep Medicine Reviews (2018) Vol. 42, pp. 139-148
Open Access | Times Cited: 78
Health-related quality of life in people with predementia Alzheimer’s disease, mild cognitive impairment or dementia measured with preference-based instruments: a systematic literature review
Filipa Landeiro, Seher Mughal, Katie Walsh, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 68
Vascular Risk Factors and Alzheimer’s Disease: Blood-Brain Barrier Disruption, Metabolic Syndromes, and Molecular Links
Jinting He, Xin Zhao, Lei Xu, et al.
Journal of Alzheimer s Disease (2019) Vol. 73, Iss. 1, pp. 39-58
Closed Access | Times Cited: 65
Clinical Guidelines for Cognitive Disorders in Elderly and Older Patients
А Н Боголепова, Е Е Васенина, N. A. Gomzyakova, et al.
S S Korsakov Journal of Neurology and Psychiatry (2021) Vol. 121, Iss. 10, pp. 6-6
Closed Access | Times Cited: 54
Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics
Valeria Calsolaro, Grazia Daniela Femminella, Sara Rogani, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 3, pp. 246-246
Open Access | Times Cited: 47
Advances in Deep Neuropathological Phenotyping of Alzheimer Disease: Past, Present, and Future
Mustafa N Shakir, Brittany N. Dugger
Journal of Neuropathology & Experimental Neurology (2022) Vol. 81, Iss. 1, pp. 2-15
Open Access | Times Cited: 38
Ischemia as a common trigger for Alzheimer’s disease
Karin Elman-Shina, Shai Efrati
Frontiers in Aging Neuroscience (2022) Vol. 14
Open Access | Times Cited: 29
Vascular dementia subtypes, pathophysiology, genetics, neuroimaging, biomarkers, and treatment updates along with its association with Alzheimer's dementia and diabetes mellitus
Priyadarshi Prajjwal, Mohammed Dheyaa Marsool Marsool, Pugazhendi Inban, et al.
Disease-a-Month (2023) Vol. 69, Iss. 5, pp. 101557-101557
Closed Access | Times Cited: 17
Atherosclerosis, Hypertension, and Diabetes in Alzheimer’s Disease, Vascular Dementia, and Mixed Dementia: Prevalence and Presentation
Keivan Javanshiri, Maria Landqvist Waldö, Niklas Friberg, et al.
Journal of Alzheimer s Disease (2018) Vol. 65, Iss. 4, pp. 1247-1258
Closed Access | Times Cited: 55
COVID-19 Crisis Effects on Caregiver Distress in Neurocognitive Disorder
Panagiotis Alexopoulos, Rigas Filippos Soldatos, Evangelia Kontogianni, et al.
Journal of Alzheimer s Disease (2020) Vol. 79, Iss. 1, pp. 459-466
Closed Access | Times Cited: 41
The rising burden of Alzheimer's disease mortality in rural America
Jessica Y. Ho, Yujin Franco
SSM - Population Health (2022) Vol. 17, pp. 101052-101052
Open Access | Times Cited: 23
Long-term low-dose acetylsalicylic use shows protective potential for the development of both vascular dementia and Alzheimer’s disease in patients with coronary heart disease but not in other individuals from the general population: results from two large cohort studies
Thi Ngoc Mai Nguyen, Li‐Ju Chen, Kira Trares, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 23
Alzheimer's disease and Alzheimer’s disease-related dementias in Hispanics: Identifying influential factors and supporting caregivers
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
Ageing Research Reviews (2023) Vol. 93, pp. 102178-102178
Closed Access | Times Cited: 15
Role of Citicoline in Patients With Mild Cognitive Impairment
Pedro Emilio Bermejo, Rodolfo Dorado, María Ascensión Zea‐Sevilla
Neuroscience Insights (2023) Vol. 18
Open Access | Times Cited: 14
Emerging Trends: Neurofilament Biomarkers in Precision Neurology
Priti Sharma, Aditi Giri, Prabhash Nath Tripathi
Neurochemical Research (2024)
Closed Access | Times Cited: 6
The Sulfation Code of Tauopathies: Heparan Sulfate Proteoglycans in the Prion Like Spread of Tau Pathology
Dylan Mah, Jing Zhao, Xinyue Liu, et al.
Frontiers in Molecular Biosciences (2021) Vol. 8
Open Access | Times Cited: 29
Hypertension & dementia: Pathophysiology & potential utility of antihypertensives in reducing disease burden
Mara Lyon, Josie Fullerton, Simon Kennedy, et al.
Pharmacology & Therapeutics (2023) Vol. 253, pp. 108575-108575
Open Access | Times Cited: 13
Page 1 - Next Page

Scroll to top